1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with beta-lactams in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 7,579 | 179 | 3,395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bondinell, W; Chabot-Flecher, M; Chilton, FH; Griswold, DE; Marshall, LA; Mayer, RJ; Sung, CM; Winkler, JD | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and beta-lactams
| Article | Year |
|---|---|
Beta-lactams SB 212047 and SB 216754 are irreversible, time-dependent inhibitors of coenzyme A-independent transacylase.
Topics: Acetyltransferases; Acyl-Carrier Protein S-Acetyltransferase; Animals; Anti-Inflammatory Agents; beta-Lactams; Cell Line; Eicosanoids; Enzyme Inhibitors; Humans; Lactams; Mice; Mice, Inbred BALB C; Microsomes; Neutrophils; Platelet Activating Factor | 1998 |